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Abstract
Xylella fastidiosa strain 9a5c is a gram-negative phytopathogen that is the causal agent of
citrus variegated chlorosis (CVC), a disease that is responsible for economic losses in Bra-
zilian agriculture. The most well-known mechanism of pathogenicity for this bacterial patho-
gen is xylem vessel occlusion, which results from bacterial movement and the formation of
biofilms. The molecular mechanisms underlying the virulence caused by biofilm formation
are unknown. Here, we provide evidence showing that virulence-associated protein D in X.
fastidiosa (Xf-VapD) is a thermostable protein with ribonuclease activity. Moreover, protein
expression analyses in two X. fastidiosa strains, including virulent (Xf9a5c) and nonpatho-
genic (XfJ1a12) strains, showed that Xf-VapD was expressed during all phases of develop-
ment in both strains and that increased expression was observed in Xf9a5c during biofilm
growth. This study is an important step toward characterizing and improving our under-
standing of the biological significance of Xf-VapD and its potential functions in the CVC
pathosystem.
Introduction
Xylella fastidiosa is a gram-negative, xylem-inhabiting bacterium that is a causal agent in
important global diseases in agricultural crops, such as plum, almond, peach, coffee, and grape-
vine [1]. X. fastidiosa causes citrus variegated chlorosis disease (CVC) in the orange trees of
Brazil, which dramatically reduces fruit production [2,3]. X. fastidiosa is transmitted by sharp-
shooter leafhoppers, and once the pathogen enters the xylem, it spreads through channels
called bordered pits that connect vessels [4]. The main pathogenic mechanism of X. fastidiosa
occurs when the organism blocks water transport through vessels by forming systemic biofilms.
A biofilm is a matrix that is composed of factors including extracellular polymeric substance
(EPS), proteins, and nucleic acids [5]. This architecture increases the resistance of the biofilm
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cells to a wide range of antagonistic agents, such as UV radiation, shifts in pH, osmotic shock,
desiccation, antimicrobial compounds, and host defense mechanisms [6]. During the biofilm
phase, diffusible signal factors are used in an intercellular communication system called quo-
rum sensing (QS) that, among other functions, controls the expression of virulence factors [7–
10]. Biofilm formation occurs through a dynamic and complex mechanism of development in
which protein expression can change after only one day of growth [11]. In X. fastidiosa, biofilm
formation on an abiotic surface involves the following five developmental steps: (1) reversible
attachment; (2) irreversible attachment; (3) the beginning of maturation, which includes
approximately 10 days of growth and the initiation of QS; (4) mature biofilm establishment,
which occurs between days 15 and 20; and (5) dispersion, which occurs between days 25 and
30 [12].
Because the Xf9a5c genome has been sequenced [13], many studies have analyzed the open-
reading frames (ORFs) in its genome to predict genes that may participate in its pathogenicity
and in biofilm formation [14–18]. However, some predicted virulence factors remain unstud-
ied. One predicted virulence factor of interest was found in the plasmid pXF51; in this plasmid,
the ORF XFb0051 encodes the 17.6 kDa virulence-associated protein D (Xf-VapD), which con-
tains a predominance of α-helices in its secondary structure [19]. Xf-VapD is predicted to
belong to the CRISPR/Cas2 family (Pfam: PF09827). CRISPRs (clustered regularly interspaced
short palindromic repeats) are DNA loci that, when associated with Cas proteins, confer resis-
tance to foreign genetic elements, such as plasmids and phages [20]. Cas2 in Legionella pneu-
mophila, a gram-negative aquatic bacterium, has been shown to be an important component
during infection of amoebal host cells [21]. In addition, several bacterial species also produce
the VapD protein. InHaemophilus influenzae, the VapXD toxin-antitoxin locus enhanced sur-
vival and virulence via a mechanism involving mRNA cleavage during in vitro and in vivo
infection tests [22]. InHelicobacter pylori, VapD has been shown to display ribonuclease activ-
ity [23], and in Rhodococcus equi, it has a β-barrel structure, but its function is unknown [24].
In this study, we performed tests to structurally and functionally characterize Xf-VapD, and
we analyzed its expression levels in two strains: 9a5c (virulent) and J1a12 (nonpathogenic). In
addition, we demonstrated that Xf-VapD is a thermostable protein with ribonuclease activity.
The expression of Xf-VapD was observed in both the Xf9a5c and the XfJ1a12 strain, but a
higher level of expression was observed in Xf9a5c during biofilm growth.
Materials and Methods
Cloning, expression, and purification
The ORF XFb0051 of X. fastidiosa (database http://www.xylella.lncc.br/) was amplified using
PCR of total DNA (genomic + plasmid) isolated from X. fastidiosa strain 9a5c, which was used
as the template. To modify the original amino acid sequence, we removed the first two residues
from its N-terminus and the last 10 residues from its C-terminus. This procedure was neces-
sary because the complete sequence caused instability in crystallographic assays aimed at deter-
mining the 3D structure of Xf-VapD (research in progress). Therefore, all experimental
procedures were performed using this modified amino acid sequence. The amino acids that
were removed did not contain any functional sites. Specific forward (5’- GGTATT
GAGGGTCGCGATCGCTGCCTAATCGTTT-3’) and reverse (5’-AGTTAGAGCCTCACG
CATTTTCTAGAGAGAACTTCT-3’) primers were designed. The PCR product obtained using
these primers was cloned into the pET32Xa/LIC vector (Novagen; USA) and used to transform
the E. coli strains DH5-α and BL21 (DE3) (Novagen; USA) to induce heterologous protein
expression. Xf-VapD protein expression and purification were performed according to the
Xf-VapD Is a Thermostable Ribonuclease
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methods described in [19] and by using an FPLC ÄKTApurifier GE1 for the chromatography
steps. The purified protein was analyzed using 12.5% SDS-PAGE [25].
CD spectroscopy and CD thermal denaturation
The purified Xf-VapD protein (2.0 μM) was dialyzed against 20 mM Tris-HCl and 10 mM
NaCl, pH 7.5, and evaluated using a JASCO J-810 circular dichroism (CD) spectropolarimeter
(Japan Spectroscopic; Tokyo, Japan) that was coupled to a temperature controller. The sample
was contained in a 0.1 cm quartz cuvette. The CD spectra were recorded in a measurement
range of 200 nm–260 nm at 25°C. The results were analyzed using the DichroWeb server [26].
For the denaturation assays, Xf-VapD CD was measured at intervals from 20°C–110°C. After a
final measurement at 110°C, the sample was cooled back down to 20°C. The sample was then
contained in a 1 cm quartz cuvette.
RNase activity assay
Xf-VapD recombinant purified protein (1.0 mg/mL) that was suspended in a buffer containing
50 mM Tris and 300 mMNaCl at pH 7.5 was incubated with a modified RNA oligonucleotide
that emits a green fluorescence when cleaved by RNase (RNaseAlert1QC System) at 37°C for
180 minutes. In this assay, we used two temperatures, 37°C and 90°C, for the Xf-VapD activity
studies. The first temperature was the same as the temperature that was used for the recombi-
nant expression of Xf-VapD, and the second temperature was used to test the enzyme’s activity
at a high temperature. For the 90°C tests, the protein was denatured for 30 minutes at 90°C and
then centrifuged (16,110 x g, 25°C, 3 minutes). The supernatant fraction was incubated at 37°C
with the modified RNA oligonucleotide for 180 minutes. A positive control (RNase A) and
negative controls (Xf-VapD purification buffer and nuclease-free water) were used in the assay.
The measurements were performed in duplicate for each experimental sample using a fluorom-
eter with excitation and emission wavelengths of 490 nm and 520 nm, respectively.
In addition, Xf-VapD RNase activity was visualized using 1% agarose gels. For these experi-
ments, total RNA was obtained from the E. coli strain BL21(DE3) using TRI Reagent1 solution
(Thermo Fisher Scientific, USA) and purified using an RNeasy1Mini Kit (Qiagen, GER). Ali-
quots containing 1.0 μg of total RNA were incubated for 1 h at 25°C with 1 μM, 5 μM, 10 μM
and 20 μM of Xf-VapD. In addition, a DNase activity test was performed. For these experi-
ments, long and a short double-stranded DNA (dsDNA) and single-stranded DNA (ssDNA)
were used. A long dsDNA (2 kb) template corresponding to multicopper oxidase was obtained
using metagenomic prospection in Caatinga soil and prepared using PCR with specific primer
pairs (Fwd, [5’-ACTGCATATGTTCGTTCAGCC-3’] and Rev, [5’-TTCGAGCTCGAGGAGC
TACC-3’]). A short dsDNA (20 bp) [5’-AGGCAGGACTATGGAGGCGA-3’] and a ssDNA
(26 nt) [5’-CCACATATGACAAACCTATTACAAGT-3’] were commercially synthesized. Ali-
quots containing 2 μg of dsDNA or ssDNA were incubated for 1 h at 25°C with 20 μM or
50 μM of Xf-VapD. The dsDNA (2 kb) was visualized using a 1% agarose gel, while the dsDNA
(20 bp) and the ssDNA (26 nt) were visualized using 20% acrylamide gels.
Expression profiles of Xf-VapD in different phases of biofilm formation
The expression level of Xf-VapD in biofilm and planktonic X. fastidiosa cells was determined
using western blot analysis with a specific anti-rabbit IgG polyclonal antibody against Xf-
VapD that was synthesized by Rhea Biotech, Brazil. Xf9a5c and XfJ1a12 cells were grown in
periwinkle wilt (PW) medium [27] for seven days until they reached A600 = 0.7. A total volume
of 2 mL of each suspension was then inoculated into a 125-mL flask containing 50 mL of PW
medium. The flasks were maintained at 28°C with rotary agitation (120 rpm) for three, five, 10,
Xf-VapD Is a Thermostable Ribonuclease
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20, 30 days. An analysis of the XfJ1a12 biofilm cells was not performed because this strain
forms a very thin biofilm in vitro. The extraction of total protein from Xf9a5c cells (biofilm and
planktonic) and XfJ1a12 cells (only planktonic) was performed according to the protocol
described in [12]. The total protein was quantified using the Bradford method and normalized
to equal concentrations. A total of 5.0 μg of protein was separated using 12.5% SDS-PAGE.
The acrylamide gel was then transferred to a nitrocellulose membrane using a Semi-Dry Trans-
fer Cell (BioRad, CA, USA). The membrane was blocked in a 1% casein solution and incubated
first with a specific antibody against Xf-VapD (dilution 1:1,000) and then with a secondary
antibody, anti-rabbit IgG conjugated to alkaline phosphatase enzyme (dilution 1:8,000). BCIP/
NBT Color Development Substrate (Promega) was used to detect alkaline phosphatase activity
and visualize the bands. The bands were quantified using ImageJ software, and the statistical
significance of the results was analyzed using two-tailed Student’s t-tests (p<0.05 was defined
as indicating statistical significance). The experiments were performed in triplicate.
Alignment, phylogenetic analysis, and protein model prediction
The VapD amino acid sequences were used to search the NCBI data bank. To analyze their
alignment, the sequences were separated according to their percentage of identity to Xf-VapD
(accession number Uniprot/NCBI: Q9PHF6/AE003851_51). Group 1 shared identity with Xf-
VapD was above 50%, group 2 was from 49 to 25%, and group 3 was below 25%. VapD
sequences were obtained for the following species: X. fastidiosa strain Ann-1 (A0A060H4 L5/
AIC11724.1), Gallibacterium anatis (A0A0A2YXK7/WP_018347295), Aggregatibacter actino-
mycetemcomitans (G4A5B7/ EGY35307), Neisseria meningitides (L5UTE0/WP_002251489);
Escherichia coli (C6CFU7/WP_001402204), Xanthomonas campestris (G2 LRG4/
WP_039405661),Haemophilus influenzae (A4NV08/WP_013526240), Helicobacter pylori
(A0A0B5FMI2/ 3UI3_B), and Rhodococcus equi (B4F3C5/4CSB). For the phylogenetic analy-
sis, the VapD sequences were aligned using TranslatorX software [28] with the Muscle Algo-
rithm. All sequences were translated into amino acids, which were then aligned and further
back-translated into nucleotide sequences. Both the amino acid and nucleotide alignments
were used to infer phylogenetic relationships between all of the identified VapD proteins. A
neighbor-joining phylogenetic tree was constructed using MEGA 5.2 [29] and inferred using
uncorrected p-distances and the partial deletion of sites (50%). Branch supports were accessed
through 1,000 bootstrap replicates. Bayesian inference analyses were performed using MrBayes
v3.1.2 [30]. The modeling of nucleotides (+I+G) and amino acids (GTR+G) was performed
using MrAIC [31] and ProtTest [32], respectively. Rhodococcus equi was used as the outgroup
for the phylogenetic tree. The final protein model was obtained using the protein homology/
analogy recognition engine server Phyre V 2.0 and the I-TASSER server [33,34].
Ethics statement
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Results
Alignment and phylogenetic analysis
The Xf-VapD amino acid sequence showed high identity to the VapD sequences of several dif-
ferent bacterial species (Fig 1). The VapD sequences analyzed in groups 1, 2 and 3 (except
those of R. equi) were found to be related to the Cas2 family of CRISPR/Cas system-associated
proteins. Using the PSIPRED secondary structure prediction method v3.3 [35], we found that
the amino acids have a secondary structure that is mainly composed of α-helices with a small
Fig 1. Multiple sequence alignments to VapD proteins.Group 1: The X. fastidiosa strains 9a5c and Ann-1 (Xf9a5c and XfAnn-1, respectively),G. anatis
(Ga), A. actinomycetemcomitans (Aa), andN.meningitides (Nm). Group 2: E. coli (Ec), X. campestris (Xc), andH. influenza (Hi). Group 3:H. pylori (Hp) and
R. equi (Re). The identity values for Xf-VapD are shown in parentheses at the end of each sequence.
doi:10.1371/journal.pone.0145765.g001
Xf-VapD Is a Thermostable Ribonuclease
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proportion of β-sheets. In group 3, the VapD sequences fromH. pylori and R. equi exhibited
low identity with Xf-VapD (18% and 12%, respectively), but their recently published structures
revealed that they display interesting characteristics. VapD in R. equi has β-barrel structural
features (PDB ID. 4CSB), whereas VapD inH. pylori has α-helix and β-sheet structural features
and endoribonuclease activity (PDB ID 3UI3) [23,24]. In a preliminary investigation of the
structure of Xf-VapD, we used the protein homology/analogy recognition engine Phyre V 2.0
[33] to identify the closed structure of Xf-VapD. We found that 66% of its sequence (Position:
5–107 or CLI—AFE) had 100% confidence (the probability that the sequences of Xf-VapD and
the template are homologous) to VapD in H. pylori (Fig 2A). This structural prediction was
confirmed using the I-TASSER server [34]. Phylogenetic analyses showed that the Xf-VapD
Fig 2. Structural and phylogenetic analysis of Xf-VapD. (A) The prediction of the 3D structure of Xf-VapD was performed using Phyre V 2.0 (red cartoon).
A model was obtained with 66% of the Xf-VapD sequence and 100% confidence using the single highest scoring template. The structure was edited using
PyMol. On the right, the amino acid sequence is shown with the respective secondary structure and confidence. The amino acid residues highlighted in red
correspond to the area in the red cartoon shown in the 3D structure. (B) The neighbor-joining consensus tree inferred for the amino acid sequences of VapD.
The values above the branches indicate the Bayesian posterior probabilities for the amino acids (PPaa) and nucleotides (PPnt). The values below the
branches indicate the results of the neighbor-joining method for the amino acids (BSaa) and nucleotides (BSnt) following 1,000 bootstrap replicates. The
minus symbol (-) indicates that no support was reached for this node. The groups are the same as those in Fig 1.
doi:10.1371/journal.pone.0145765.g002
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and VapD in groups 1 and 2 and H. pylori are homologues and form a distinct clade, while the
Xf-VapD and VapD of R. equi do not appear to share the same evolutionary course (Fig 2B).
Recombinant Xf-VapD expression and purification
Xf-VapD was successfully expressed and purified using the well-established protocol that is
described in [19]. The complete amino acid sequence was modified by removing amino acids
to perform the posterior crystallographic assay, as described in the experimental procedures. In
the first step of the purification, Xf-VapD fused to a thioredoxin (trx-tag) was obtained with a
molecular mass of approximately 30 kDa. In the second step, after cleavage with a 1 mg/mL
trypsin solution, purified Xf-VapD (6.85 mg/L of bacterial culture) was obtained with a molec-
ular mass of 16.5 kDa (Fig 3). Protein identity was confirmed using mass spectrometry.
Secondary structure and thermo stability assay of Xf-VapD
The secondary structure of Xf-VapD was determined using CD spectroscopy data. This analy-
sis revealed a high proportion of α-helices (69%) and a minor β-sheet component (19%)
(Fig 4A). CD spectroscopy was also used to determine the thermodynamic stability of Xf-
VapD. For these experiments, the recombinant protein was tested along a temperature gradient
ranging from 20°C to 100°C. During the heating phase, Xf-VapD had shown a capacity to with-
stand a high temperature and a Tm of 83°C (Fig 4B). The cooling phase did not result in the
refolding of Xf-VapD. This irreversible denaturation generally occurs as a result of the aggrega-
tion of unfolded polypeptides [36].
Fig 3. Purification of recombinant Xf-VapD. A chromatogram showing the two steps used in the purification of Xf-VapD: Xf-VapD fused with a trx-tag was
obtained first, and then trypsin cleavage was used to remove the trx-tag. On the right, a 12.5% SDS-PAGE is shown for the Xf-VapD purification process. The
lanes are as follows: M, protein marker; 1, Xf-VapD fused to trx-tag (31 kDa); 2, Xf-VapD and trx-tag after cleavage with trypsin; 3, totally purified Xf-VapD
(16.5 kDa); and 4, trx-tag (~13 kDa). The gel was stained using Coomassie brilliant blue.
doi:10.1371/journal.pone.0145765.g003
Xf-VapD Is a Thermostable Ribonuclease
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Functional characterization of Xf-VapD
Ribonuclease activity has been observed in VapD and CRISPR-associated Cas2 proteins
[21,23]. Thus, a ribonuclease activity assay was performed using an RNase detection kit (RNa-
seAlert1QC System, Life Technologies, USA) to determine whether Xf-VapD has a similar
protein function. This kit is composed of a modified RNA that emits green fluorescence when
cleaved by RNase. Activity was tested at two temperatures (37°C and 90°C). Xf-VapD showed
ribonuclease activity at both temperatures. Heating the test solution to 90°C resulted in a 50%
reduction in the maximum relative fluorescence units (RFU) compared to the RFU observed at
37°C (Fig 5A), which supported the results of the CD unfolding experiments. The positive con-
trol (ribonuclease A) and the negative controls (Xf-VapD buffer and nuclease-free water) cor-
responded to the results observed in the quality assay. The basal values in the negative controls
(close to 250 RFU) were normal according to the kit protocol. In vitro tests performed using
total RNA obtained from E. coli also demonstrated the ribonuclease activity of Xf-VapD at dif-
ferent protein concentrations (Fig 5B). In addition, interaction tests using long (2 kb) and
short (20 bp) dsDNA and ssDNA (26 nt) were performed. However, Xf-VapD did not show a
level of activity that is equivalent to the level found using RNA substrates (Fig 5C–5E).
Analysis of Xf-VapD expression in different biofilm and planktonic growth
phases
The function of VapD remains unknown in many organisms. As shown in Fig 5, Xf-VapD
demonstrated ribonuclease activity, which is an important function that has been observed in
members of the CRISPR/Cas2 system [37]. X. fastidiosa has two modes of growth. Planktonic
growth occurs when the cells are dispersed in the media, while biofilm growth involves the cells
adhering to biotic or abiotic surfaces and multiplying to form microcolonies. Biofilm growth is
an important feature of virulence symptoms in CVC [9]. Thus, we next evaluated protein
expression levels in the Xf9a5c and XfJ1a12 strains during the following five growth
Fig 4. Secondary structure and thermo stability assay of Xf-VapD. (A) Circular dichroism spectrum (200 nm–260 nm) of the recombinant purified Xf-
VapD. The secondary structure of the protein was found to be 69% α-helices, 19% β-sheets, and 12% random coils. (B) Thermal unfolding/refolding of Xf-
VapD. At 83°C during the heating phase, 50% of the proteins were unfolded (red marker). The conformational structure of the protein was not restored during
the cooling phase.
doi:10.1371/journal.pone.0145765.g004
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timepoints: reversible attachment (at three days), irreversible attachment (at five days), initial
maturation (at 10 days), mature biofilm (at 20 days), and dispersion (at 30 days). Planktonic
cells were also analyzed at the same time points. An important feature of the nonpathogenic
XfJ1a12 strain is its inability to form a thick biofilm to induce CVC symptoms when inoculated
in citrus plants [38,39]. Thus, we used this nonpathogenic strain as a control to determine
whether there is a difference in Xf-VapD expression between virulent and non-virulent strains
because Xf-VapD has been associated with virulent characteristics.
During the biofilm growth induced by Xf9a5c, an increase in Xf-VapD expression was
detected, and this increase was correlated with the development of the biofilm (Fig 6A). The
expression of Xf-VapD was significantly increased in this strain between days 20 and 30, which
are timepoints that correspond to the mature biofilm and dispersion stages, respectively. In
these cells, during the planktonic growth phase, no significant difference in Xf-VapD expres-
sion was observed between days three, five and 10, but Xf-VapD expression was increased on
days 20 and 30 of growth. However, in the XfJ1a12 cells, while Xf-VapD was expressed during
all stages of planktonic growth, no significant difference was found between its expression on
days 20 and 30 of growth, unlike what was observed in the virulent strain (Fig 6B). A decrease
in VapD expression was observed in this strain on only the 5th day.
Fig 5. Enzymatic activity assay of Xf-VapD. (A) The lanes contain one positive control, two negative controls, and the Xf-VapD samples that were treated
at 37°C and 90°C. The values are shown in RFU/time units. The curves show that Xf-VapD demonstrated ribonuclease activity at both 37°C, and after
heating to 90°C. (B) Lane 1 contains RNA alone, and lanes 2 to 5 contain RNA with Xf-VapD (1 μM, 5 μM, 10 μM and 20 μM, respectively). (C) Lane 1
contains dsDNA (2 kb) alone, and lanes 2 to 3 contain dsDNA (2 kb) with Xf-VapD (20 μM and 50 μM, respectively). (D) Lane 1 contains dsDNA (20 bp)
alone, and lanes 2 to 3 contain dsDNA (20 bp) with Xf-VapD (20 μM and 50 μM, respectively). (E) Lane 1 contains ssDNA (26 nt) alone, and lane 2 contains
ssDNA (26 nt) with Xf-VapD (50 μM).
doi:10.1371/journal.pone.0145765.g005
Xf-VapD Is a Thermostable Ribonuclease
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Discussion
The main mechanism of the pathogenicity of X. fastidiosa lies in its capacity to form biofilms,
which cause vascular occlusions inside xylem vessels, leading to water stress [40]. However,
many of the molecular mechanisms involved in its virulence have not been fully explored.
Interestingly, 64 ORFs have been predicted in the pXF51 plasmid of Xf9a5c. Among these,
only one, Xfb0051, which encodes Xf-VapD, has been associated with the pathogenesis caused
by vascular occlusions [13,41]. Xf-VapD is characterized as a virulence-associated protein, but
its contributions to virulence and pathogenicity are not understood. However, by definition,
virulence-associated genes must act in one of three ways: by regulating the expression of viru-
lence genes, by activating virulence factors via translational modification, processing or secre-
tion, or by co-activating true virulence factors [42].
In the NCBI data bank, Xf-VapD is annotated as the CRISPR system-associated protein
Cas2, which has been associated with endoribonuclease activity. In addition to conferring
immunity against phages and plasmids, the Cas2 proteins are virulence factors in L. pneumo-
phila [21]. Most VapD proteins in bacterial species have unknown functions. The PDB data
bank (http://www.rcsb.org) contains only two resolved VapD structures, 3UI3 and 4CSB
[23,24]. However, these two structures are very different, suggesting that they have distinct
functions. Xf-VapD has high identity with VapD in several bacteria. Phylogenetic analyses
have shown that the VapD sequences inH. pylori and R. equi are not closely related with Xf-
VapD (Fig 2B). However, an in silico prediction showed that Xf-VapD has high structural and
functional homology with VapD in H. pylori (3UI3) (Fig 2A). The structural and functional
similarities between Xf-VapD and VapD in H. pylori, in addition to the high identity observed
in these sequences in other species, suggest that a change occurred along the evolutionary
course of VapD that led to the preservation of functions between homologous species.
In the present study, we demonstrate that Xf-VapD is a thermostable protein (Fig 4B). Sev-
eral factors are associated with thermal stability, including hydrophobic interactions, ionic
Fig 6. Western blot analyses of Xf-VapD expression in X. fastidiosa cells. (A) Strain 9a5c in planktonic and biofilm growth. (B) Strain J1a12 in planktonic
growth. The band values were obtained using ImageJ software. The values above the bars indicate the average of three biological replicates. The error bars
indicate the standard errors of the means. The asterisk (*) indicates a significant difference compared to the days of growth indicated in the brackets
(Student’s t-test, p<0.05).
doi:10.1371/journal.pone.0145765.g006
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interactions, and amino acid preference. However, the specific contributions of these factors
vary among different proteins, and this makes them difficult to explore [43,44]. The necessity
of any one of these characteristics in a protein is usually associated with the maintenance of
structural folds and functional activities under extreme environmental conditions [45]. The
hostile environment inside xylem vessels is caused by factors including a low concentration of
solutes in the sap and oscillations in these concentrations [46], and these may require a patho-
gen to be more resistant to antagonistic agents. In this way, protein stabilization by hydropho-
bic interactions can, for example, play an important role in the spread of bacteria within a host.
Heat resistance is a common characteristic of ribonucleases [47–49]. This motivated us to
investigate this heat resistance in Xf-VapD. Enzymatic tests showed that at 37°C, Xf-VapD has
ribonuclease activity. After heating the solution to 90°C, Xf-VapD maintained 50% of its activ-
ity. Ribonucleases are associated with the establishment of virulence in many pathogenic bacte-
ria, in which they act to regulate non-coding RNAs at several levels, including their biogenesis,
processing and turnover [50,51]. In Vibrio cholera, for example, the YbeY protein is a ribonu-
clease that is essential for virulence and stress regulation [52], whereas ribonuclease R is a viru-
lence factor that is important during the first steps of infection, adhesion and invasion of
eukaryotic cells by Campylobacter jejuni [53].
Our preliminary investigation of the structural and functional characteristics of Xf-VapD is
an important step towards understanding the role of this protein. In this study, we show that
the secondary structure of Xf-VapD is 69% α-helices and 19% β-sheets. These results support
previous structural predictions in which PSIPRED was used. Moreover, a new strategy for
expressing a modified amino acid sequence of the protein was necessary to avoid instabilities
that were observed during crystallographic assays (data not shown). Research is in progress to
determine the 3D structure of Xf-VapD.
The expression of Xf-VapD was observed in Xf9a5c and XfJ1a12 cells. In prokaryotes, ribo-
nucleases participate in the transcriptional and post-transcriptional control of gene expression,
in regulating plasmid replication, and in maintaining the transfer of genetic material by con-
trolling the levels of antisense RNAs and small RNAs [54–57].
Interestingly, differences in the expression profile of Xf-VapD between virulent and non-
pathogenic strains were observed in planktonic cells. While Xf-VapD expression in the virulent
strain, Xf9a5c, increased as cell growth increased (Fig 6A), the non-virulent XfJ1a12 cells did
not exhibit similar behavior (Fig 6B). An analysis of Xf-VapD levels in the biofilms of XfJ1a12
cells was not performed because this strain forms a very thin biofilm in vitro. During Xf9a5c
biofilm growth, an increase in the expression of Xf-VapD was observed from day 20 to day 30
during both biofilm and planktonic growth (Fig 6A). These results support the findings of
studies of VapD gene expression in X. fastidiosa [58].
The results of this study indicate that there is a need to increase the number of studies inves-
tigating Xf-VapD and the mechanisms that contribute to its virulence. These should include
studies that use site-directed mutagenesis assays. The functional characterization of Xf-VapD
as a thermostable ribonuclease that is primarily expressed in the mature biofilms of the virulent
9a5c strain is an important step toward increasing our understanding of the biological signifi-
cance of Xf-VapD in this pathosystem.
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